Simon H. Szewach

Simon H. Szewach

Executive Chairman

Simon H. Szewach is one of our co-founders and has been our Executive Chairman and Director of the Company since August 2021. He has extensive experience in commercial sales and marketing of new products trends in the finance, technology and sport sectors.

His responsibilities to the Company include oversight of:

  1. our sales and strategic partnerships and alliances,
  2. our marketing activities and strategy,
  3. IR and M&A activity,
  4. international sales expansion and
  5. our company strategy — in particular sales, marketing and finance.

His prior work experience in sales, marketing and technology includes serving as a managing partner of The Legats Group, a Melbourne-based company that invests in leading-edge start-ups with strong competitive advantages through innovative technologies and intellectual property, from November 2016 to present. Prior to that, Mr. Szewach served as the co-founder and managing director of nTouch Pty Ltd, a proximity-based marketing platform, from 2013 to 2015. In 2015, YPB group Ltd (ASX:YPB), a brand protection company, acquired nTouch Pty Ltd, and Mr. Szewach then served as President of Consumer Engagement at YPB Group Ltd from 2015 to 2017. He was the co-founder and chief executive officer of StartHere.com.au, an incentive-based shopping platform, from 2012 to 2015. Mr. Szewach is also the co-founder and a member of the board of directors of the Sports Diplomacy Alliance, founded in September 2021, and is also on the board of directors of ReviverMx Inc, from January 2017 to present, Global Reviews Holding Pty Ltd, from June 2012 to present, and Waratek Inc. from February 2018 to present.

Mr. Szewach received both his Bachelor of Business in Banking & Finance and a Bachelor of Arts in Asian Studies (Korean) respectively from Monash University in 2003.

Nathan J. Givoni

Nathan J. Givoni

CEO and Director

Nathan J. Givoni is one of our co-founders and has been our Chief Executive Officer and a Director of the Company since our inception. He is a health professional with over 15 years of experience in the health and medical fields.

His responsibilities to the Company include oversight of:

  1. the day-to-day operation of our business,
  2. day-to-day science and formulations of new and existing product,
  3. manufacturing and supply chain of our business,
  4. all intellectual property matters relating to our business and
  5. the suppliers to our business.

He is the founder and Managing Director of Lifestyle Breakthrough Pty Ltd, a medical and allied health consulting service with locations across Australia, from July 2011 to present. Mr. Givoni is also the Science and Nutrition Expert at The Legats Group from March 2019 to present and the founder of the Metabolic Health Foundation, founded in Australia in March 2022 to present.

Mr. Givoni received a Bachelor of Science in Physiology & Psychology in 2006, a Bachelor of Science in Physiology (First Class Honors) in 2007 and a Bachelor of Nutrition and Dietetics in 2009 respectively from Monash University. He worked as an adjunct lecturer at Monash University from 2014 to 2017, publishing multiple papers post his undergraduate degree. He has trained and worked as both a dietitian and exercise physiologist, bringing clinical knowledge to our business.

Anthony W. Panther

Anthony W. Panther

Chief Financial Officer

Anthony W. Panther has been the Chief Financial Officer of the Company since February 2024. Mr. Panther is concurrently employed as a Senior Manager at Vistra, since March 2018, a global professional services firm. At Vistra, Mr. Panther provides CFO and Company Secretary services to a portfolio of ASX listed companies in the technology, medical services and mineral exploration sectors. Prior to this role, Mr. Panther was Chief Financial Officer at Jayex Technology Limited (ASX:JTL) from August 2016 to March 2018, Senior Manager at Leydin Freyer Corporate from February 2015 to August 2016, Chief Financial Officer at CleanTeq Holdings Limited (ASX:CLQ) from January 2013 to February 2015 and Chief Financial Officer and Company Secretary at General Biosystems (ASX:GBI) from November 2009 to December 2012. Prior to November 2009, Mr. Panther held various financial management, compliance, internal audit and company secretarial roles in companies across various industries, including Cogstate Ltd (ASX:CGS), OFM Investment Group (ASX:OFM) and Retail Energy Market Company Limited, and held external auditor roles with KPMG Peat Marwick and Hughes Fincher.

Mr. Panther qualified as a Chartered Accountant in 1988 and received a dual Bachelor of Economics and Bachelor of Laws from Monash University in 1985 and a Graduate Diploma in Applied Corporate Governance from the Governance Institute of Australia in 2008.

Mr. Panther’s responsibilities to the Company include:

  1. providing financial advice and analysis to the Board of Directors and CEO on all strategic and operational aspects of financial management for the company,
  2. ensuring implementation of robust financial, corporate management and business intelligence systems & processes to increase organizational efficiency, accountability, transparency and effective decision-making,
  3. managing financial reporting for the organization. This includes monthly financial reporting, budgeting and forecasting, financial plans and all statutory financial reporting,
  4. overseeing accounts payable, accounts receivable, tax, treasury, payroll, financial and management accounting functions,
  5. managing the relationship with auditors, banks, tax and other external authorities,
  6. ensuring financial strength is maintained through effective cash flow management and appropriate investment strategies,
  7. ensuring that all necessary policies and procedures to safeguard assets and minimize financial and commercial risks are in place.

Dr. Paul Wynne

Chief Scientific Officer

Dr. Wynne has over 35 years of experience in the disciplines of analytical chemistry, the design and manufacture of advanced materials, drug metabolism, pharmaceutical formulation, drug delivery and forensic toxicology. Prior to joining Gelteq, he was the Manager of the Medicines Manufacturing Innovation Centre at Monash University in Melbourne for eight years, which works to strengthen the pharmaceutical and allied manufacturing sector in Australia for domestic and International clients. Monash University is ranked #2 in the world in pharmacy and pharmaceutical science by the QS World University Rankings by Subject 2024: Pharmacy & Pharmacology. Dr. Wynne is also the author of over 80 peer reviewed papers, book chapters, and patents, and more than 120 lectures, presentations and industry technical articles. He holds a Bachelor of Applied Science (Applied Chemistry), Master of Applied Science (Organic Photochemistry), and a Doctor of Philosophy (Chemistry and Toxicology) from RMIT University.